A small-scale pilot study has linked omega-3 fatty acid supplementation to…

Baylor St. Luke’s Medical Center in Houston has hired two new cardiac surgeons and an administrator in an effort to revamp a heart transplant program that recently…

The HeartMate 3 left ventricular assist device (LVAD) has gained FDA approval for advanced heart failure patients ineligible for a transplant, manufacturer Abbott announced Oct. 19.

The heart pump was approved as a…

Cleveland Clinic researchers identified amyloid deposits in 10.2 percent of patients undergoing carpal tunnel release surgery, suggesting biopsies of hand tissue could be an early signal of life-threatening…

Women with a history of cardiotoxicity from previous cancer treatments are around 30 percent more likely to experience clinical congestive heart failure (CHF) before, during or after pregnancy, according to research published ahead of print this…

Harvard Medical School scientists have created a wirelessly programmed, miniaturized pacemaker which functions for weeks to months at a time, opening the door to “previously impossible investigations of arrhythmia and heart failure in the…

Digoxin, a cardiac glycoside popularly sold under the brand name Lanoxin, poses a major threat to the heart health of atrial fibrillation (AF) and heart failure (HF) patients, according to a…

Women who suffer from peripartum cardiomyopathy (PPCM) will likely be clinically asymptomatic seven years after they give birth, according to research published in the …

Heart failure (HF) patients who experience moderate functional mitral regurgitation (FMR) for at least six months after cardiac resynchronization therapy (CRT) are at an increased risk for death, researchers suggest in a…

The results of the COAPT trial dropped like a thunderclap Sunday at the Transcatheter Cardiovascular Therapeutics (TCT) annual…

A Journal of the American College of Cardiology study this week linked long-term alcohol consumption to adverse cardiac remodeling in patients who were initially young and…

Heart failure patients who are discharged from the hospital before they reach euvolemia—a healthy balance of blood in the body—are more likely to be readmitted in both the short- and long-term, according to…

Hospice use in the U.S. has grown to nearly 5 percent among elderly patients with heart failure (HF), according to a JAMA Cardiology study published Aug.…

Less than two weeks after the FDA sent a warning letter to cardiologists about high mortality and…

Cardiac patients diagnosed with “broken heart syndrome” are twice as likely to face clinical complications during treatment if they have a history of cancer, Italian researchers reported this week at the ESC Congress in Munich.

Broken…

Research presented this week at the European Society of Cardiology (ESC) Congress in Munich suggests a new treatment may be emerging for…

Oregon’s only heart transplant program has suspended operations for at least two weeks after three cardiologists either left or announced plans to leave Oregon Health & Science University, The Oregonian reported Aug. 27.

Although heart failure researchers have made strides in enrolling more racial and ethnic minorities in clinical trials, women and older patients remain underrepresented, according to a systematic review published in …

A new study in JAMA Cardiology uncovered a set of genetic variants that are almost exclusive to people of African ancestry and may explain their…

The FDA on Aug. 17 sent a letter warning cardiologists about high mortality and stroke rates associated with the Temporary Total Artificial…

Originally thought to be a benign condition, Takotsubo syndrome is associated with long-term outcomes similar to acute coronary syndrome (ACS), researchers reported in the Journal of…